Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

1.

CD133 mRNA expression and microsatellite instability in colorectal carcinoma.

Huh JW, Park YS, Lee JH, Kim HR, Shin MG, Kim YJ.

J Surg Oncol. 2010 Dec 1;102(7):765-70. doi: 10.1002/jso.21734.

PMID:
20872808
[PubMed - indexed for MEDLINE]
2.

Differential expression of CD133 based on microsatellite instability status in human colorectal cancer.

Park JJ, Kwon JH, Oh SH, Choi J, Moon CM, Ahn JB, Hong SP, Cheon JH, Kim TI, Kim H, Kim WH.

Mol Carcinog. 2014 Feb;53 Suppl 1:E1-10. doi: 10.1002/mc.21971. Epub 2012 Oct 12.

PMID:
23065858
[PubMed - indexed for MEDLINE]
3.

Difference between proximal and distal microsatellite-unstable sporadic colorectal cancers: analysis of clinicopathological and molecular features and prognoses.

Kim YH, Min BH, Kim SJ, Choi HK, Kim KM, Chun HK, Lee H, Kim JY, Chang DK, Son HJ, Rhee PL, Rhee JC, Kim JJ.

Ann Surg Oncol. 2010 May;17(5):1435-41. doi: 10.1245/s10434-009-0888-4. Epub 2010 Jan 5.

PMID:
20049642
[PubMed - indexed for MEDLINE]
4.

A gene signature distinguishing CD133hi from CD133- colorectal cancer cells: essential role for EGR1 and downstream factors.

Ernst A, Aigner M, Nakata S, Engel F, Schlotter M, Kloor M, Brand K, Schmitt S, Steinert G, Rahbari N, Koch M, Radlwimmer B, Weitz J, Lichter P.

Pathology. 2011 Apr;43(3):220-7. doi: 10.1097/PAT.0b013e328344e391.

PMID:
21436631
[PubMed - indexed for MEDLINE]
5.

Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients.

Artells R, Moreno I, Díaz T, Martínez F, Gel B, Navarro A, Ibeas R, Moreno J, Monzó M.

Eur J Cancer. 2010 Feb;46(3):642-9. doi: 10.1016/j.ejca.2009.11.003. Epub 2009 Dec 11.

PMID:
20005089
[PubMed - indexed for MEDLINE]
6.

Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution.

Metellus P, Nanni-Metellus I, Delfino C, Colin C, Tchogandjian A, Coulibaly B, Fina F, Loundou A, Barrie M, Chinot O, Ouafik L, Figarella-Branger D.

Ann Surg Oncol. 2011 Oct;18(10):2937-45. doi: 10.1245/s10434-011-1703-6. Epub 2011 Apr 9.

PMID:
21479688
[PubMed - indexed for MEDLINE]
7.

Clinical significance of BMP7 in human colorectal cancer.

Motoyama K, Tanaka F, Kosaka Y, Mimori K, Uetake H, Inoue H, Sugihara K, Mori M.

Ann Surg Oncol. 2008 May;15(5):1530-7. doi: 10.1245/s10434-007-9746-4. Epub 2008 Feb 8.

PMID:
18259822
[PubMed - indexed for MEDLINE]
8.

Immunohistochemical detection of CD133 expression in colorectal cancer: a clinicopathological study.

Kojima M, Ishii G, Atsumi N, Fujii S, Saito N, Ochiai A.

Cancer Sci. 2008 Aug;99(8):1578-83. doi: 10.1111/j.1349-7006.2008.00849.x.

PMID:
18754869
[PubMed - indexed for MEDLINE]
9.

Elevated expression of the stem cell marker CD133 associated with Line-1 demethylation in hepatocellular carcinoma.

Zhang C, Xu Y, Zhao J, Fan L, Jiang G, Li R, Ling Y, Wu M, Wei L.

Ann Surg Oncol. 2011 Aug;18(8):2373-80. doi: 10.1245/s10434-011-1599-1. Epub 2011 Feb 18.

PMID:
21331808
[PubMed - indexed for MEDLINE]
10.

Is CD133 mRNA expression a prognostic factor in colorectal cancer?

Hayama T, Watanabe T, Iinuma H.

J Surg Oncol. 2011 Jul 1;104(1):110. doi: 10.1002/jso.21895. Epub 2011 Mar 1. No abstract available.

PMID:
21360712
[PubMed - indexed for MEDLINE]
11.

Demethylation of the CD133 gene is frequently detected in advanced colorectal cancer.

Hibi K, Sakata M, Kitamura YH, Sakuraba K, Shirahata A, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, Nemoto H, Sanada Y.

Anticancer Res. 2009 Jun;29(6):2235-7.

PMID:
19528487
[PubMed - indexed for MEDLINE]
Free Article
12.

Predictive value of cancer stem-like cells and cancer-associated genetic markers for peritoneal recurrence of colorectal cancer in patients after curative surgery.

Nakamura K, Iinuma H, Aoyagi Y, Shibuya H, Watanabe T.

Oncology. 2010;78(5-6):309-15. doi: 10.1159/000318862. Epub 2010 Jul 9.

PMID:
20616575
[PubMed - indexed for MEDLINE]
13.

Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.

Saigusa S, Tanaka K, Toiyama Y, Yokoe T, Okugawa Y, Ioue Y, Miki C, Kusunoki M.

Ann Surg Oncol. 2009 Dec;16(12):3488-98. doi: 10.1245/s10434-009-0617-z.

PMID:
19657699
[PubMed - indexed for MEDLINE]
14.

HLA-DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancers.

Walsh MD, Dent OF, Young JP, Wright CM, Barker MA, Leggett BA, Bokey L, Chapuis PH, Jass JR, Macdonald GA.

Int J Cancer. 2009 Sep 1;125(5):1231-7. doi: 10.1002/ijc.24484.

PMID:
19462453
[PubMed - indexed for MEDLINE]
15.

Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer.

Bettstetter M, Woenckhaus M, Wild PJ, Rümmele P, Blaszyk H, Hartmann A, Hofstädter F, Dietmaier W.

J Pathol. 2005 Apr;205(5):606-14.

PMID:
15714592
[PubMed - indexed for MEDLINE]
16.

Salinomycin selectively targets 'CD133+' cell subpopulations and decreases malignant traits in colorectal cancer lines.

Dong TT, Zhou HM, Wang LL, Feng B, Lv B, Zheng MH.

Ann Surg Oncol. 2011 Jun;18(6):1797-804. doi: 10.1245/s10434-011-1561-2. Epub 2011 Jan 26.

PMID:
21267784
[PubMed - indexed for MEDLINE]
17.

Correlation of aberrant expression of CD133 with FHIT and malignant phenotype of colorectal adenocarcinoma.

Li H, Zhao P, Lu Y, Lu Y.

Int J Colorectal Dis. 2012 Aug;27(8):1015-20. Epub 2012 Feb 9.

PMID:
22315171
[PubMed - indexed for MEDLINE]
18.

Age-related alteration in the association of microsatellite instability with absent hMLH1 expression and histological types of colorectal carcinoma.

Arai T, Sugai T, Kasahara I, Sawabe M, Honma N, Aida J, Nakamura S, Takubo K.

Pathol Int. 2006 Oct;56(10):597-603.

PMID:
16984616
[PubMed - indexed for MEDLINE]
19.

CD133 expression is not an independent prognostic factor in stage II and III colorectal cancer but may predict the better outcome in patients with adjuvant therapy.

Mia-Jan K, Jung SY, Kim IY, Oh SS, Choi E, Chang SJ, Kang TY, Cho MY.

BMC Cancer. 2013 Mar 28;13:166. doi: 10.1186/1471-2407-13-166.

PMID:
23537343
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Expression of LGR5, an intestinal stem cell marker, during each stage of colorectal tumorigenesis.

Takeda K, Kinoshita I, Shimizu Y, Matsuno Y, Shichinohe T, Dosaka-Akita H.

Anticancer Res. 2011 Jan;31(1):263-70.

PMID:
21273608
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk